ref_name,rx_name,iso_name,section,assay_name,potency_type,potency,cumulative_count,potency_upper_limit,potency_lower_limit,potency_unit,date_added
Takashita22b,GS-441524,hCoV-19/Japan/UT-NCD1288-2N/2022,Table 1,Virus isolate,IC50,2.85,1,10000,0.1,uM,2022-03-17
Takashita22b,EIDD-1931,hCoV-19/Japan/UT-NCD1288-2N/2022,Table 1,Virus isolate,IC50,0.67,1,10000,0.1,uM,2022-03-17
Takashita22b,PF-07321332,hCoV-19/Japan/UT-NCD1288-2N/2022,Table 1,Virus isolate,IC50,6.76,1,10000,0.1,uM,2022-03-17
Takashita22b,GS-441524,SARS-CoV-2/UT-NC002-1T/Human/2020/Tokyo,Table S2,Virus isolate,IC50,1.04,1,10000,0.1,uM,2022-03-17
Takashita22b,EIDD-1931,SARS-CoV-2/UT-NC002-1T/Human/2020/Tokyo,Table S2,Virus isolate,IC50,0.51,1,10000,0.1,uM,2022-03-17
Takashita22b,PF-07321332,SARS-CoV-2/UT-NC002-1T/Human/2020/Tokyo,Table S2,Virus isolate,IC50,3.59,1,10000,0.1,uM,2022-03-17